What are Harmony Biosciences Holdings, Inc.'s profit margins?

Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.

Where do Harmony Biosciences Holdings, Inc.'s ratios come from?

Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Harmony Biosciences Holdings, Inc. HRMY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	76.5%-1.8pp	77.2%-0.9pp	77.7%-1.0pp	78.3%-1.1pp	78.3%-0.9pp
Operating margin	21.1%-5.1pp	24%-2.7pp	27.3%+1.6pp	28.7%+1.6pp	26.2%-6.8pp
Net margin	16.2%-4.3pp	18.3%-2.1pp	22.5%+4.5pp	23.4%+5.9pp	20.5%-1.8pp
EBITDA margin	23.7%-5.7pp	26.8%-3.3pp	30.2%+0.9pp	31.8%+0.9pp	29.4%-7.5pp
Returns
Return on equity	17.9%-6.9pp	20.8%-5.1pp	25.9%+3.2pp	27.6%+5.1pp	24.7%-4.0pp
Return on assets	12.5%-3.5pp	14%-2.1pp	17.4%+3.0pp	18.4%+4.2pp	16.1%-1.6pp
Return on invested capital	31.2%-7.3pp	45.6%+6.4pp	48.3%+15.7pp	44%+11.8pp	38.5%-2.8pp
Efficiency
Asset turnover	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×
Inventory turnover	36.2×+9.8×	31.6×+6.6×	26.7×+2.4×	28.5×+2.8×	26.4×+0.6×
Liquidity
Current ratio	3.6×-0.1×	3.6×+0.3×	3.8×+0.5×	3.8×+0.7×	3.7×+0.6×
Quick ratio	3.6×-0.1×	3.6×+0.3×	3.7×+0.5×	3.8×+0.7×	3.6×+0.6×
Cash ratio	2.7×-0.1×	3×+0.4×	2.9×+0.5×	3×+0.9×	2.8×+0.6×
Leverage
Debt-to-equity	0.2×-0.1×	0.2×-0.1×	0.2×-0.1×	0.2×-0.1×	0.2×-0.1×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×-0.1×	0.2×-0.1×	0.2×-0.1×
Net debt / EBITDA	-2×-0.6×	-2.5×-1.2×	-1.9×-0.9×	-1.5×-0.9×	-1.4×-0.8×
Interest coverage	13.5×+1.9×	14.2×+3.3×	14.7×+5.0×	13.8×+5.2×	11.6×+2.6×
Per Share
Book value per share	$15.49+25.8%	$14.86+30.5%	$14.22+38.5%	$13.23+41.4%	$12.31+37.6%
Valuation
Market capitalization	$1.62B-14.9%	$2.16B+9.8%	$1.59B-30.2%	$1.84B+7.5%	$1.9B-0.2%
Enterprise value	$1.2B-24.9%	$1.57B-7.0%	$1.11B-46.5%	$1.47B-7.3%	$1.59B-9.9%
Price / earnings	11.1×-1.3×	13.6×+0.1×	8.5×-10.0×	10.2×-4.7×	12.5×-1.4×
Price / sales	1.8×-0.8×	2.5×-0.3×	1.9×-1.4×	2.4×-0.2×	2.6×-0.5×
Price / book	1.8×-0.9×	2.5×-0.5×	1.9×-1.9×	2.4×-0.8×	2.6×-1.1×
EV / EBITDA	5.6×-1.7×	6.8×-1.1×	4.4×-5.9×	6×-1.8×	7.3×-0.5×
EV / sales	1.3×-0.8×	1.8×-0.6×	1.3×-1.7×	1.9×-0.5×	2.1×-0.7×
Earnings yield	9%+1.0pp	7.4%-0.1pp	11.7%+6.3pp	9.8%+3.1pp	8%+0.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?: Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.
Where do Harmony Biosciences Holdings, Inc.'s ratios come from?: Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.